Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 24, 2023 - Issue 1-2
Submit an article Journal homepage
324
Views
0
CrossRef citations to date
0
Altmetric
Epidemiology

Occupational lead exposure and survival with amyotrophic lateral sclerosis

Te-Wei Wang1 Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USAView further author information
,
Joanne Wuu2 Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USAView further author information
,
Anne Cooley2 Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USAView further author information
,
Tian-Shin Yeh3 Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA, and;4 Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USAView further author information
,
Michael Benatar2 Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4241-5135View further author information
ORCID Icon &
Marc Weisskopf1 Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA;3 Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA, andCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4513-9834View further author information
ORCID Icon
Pages 100-107 | Received 31 Aug 2021, Accepted 21 Mar 2022, Published online: 09 Apr 2022

References

  • Logroscino G, EURALS, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
  • Al-Chalabi A, Fang F, Hanby MF, Leigh PN, Shaw CE, Ye W, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry. 2010;81:1324–6.
  • Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617–28.
  • Dion PA, Daoud H, Rouleau GA. Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat Rev Genet. 2009;10:769–82.
  • Ajroud-Driss S, Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis (ALS). Biochim Biophys Acta. 2015;1852:679–84.
  • Zhang ZX, Anderson DW, Mantel N, Roman GC. Motor neuron disease on Guam: temporal occurrence, 1941-85. Acta Neurol Scand. 1995;92:299–307.
  • Factor-Litvak P, Al-Chalabi A, Ascherio A, Bradley W, Chio A, Garruto R, et al. Current pathways for epidemiological research in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14 Suppl 1: 33–43.
  • del Aguila MA, Longstreth WT, Jr., McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003;60:813–9.
  • Chio A, Eurals Consortium, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10:310–23.
  • Cudkowicz ME, McKenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol. 1997;41:210–21.
  • Bali T, Self W, Liu J, Siddique T, Wang LH, Bird TD, et al. Defining SOD1 ALS natural history to guide therapeutic clinical trial design. J Neurol Neurosurg Psychiatry. 2017;88:99–105.
  • Benatar M, Wuu J, Andersen PM, Atassi N, David W, Cudkowicz M, et al. Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS. Neurology 2018;90:e565–e74.
  • Wang MD, Little J, Gomes J, Cashman NR, Krewski D. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology 2017;61:101–30.
  • Bressler J, Kim KA, Chakraborti T, Goldstein G. Molecular mechanisms of lead neurotoxicity. Neurochem Res. 1999;24:595–600.
  • Garza A, Vega R, Soto E. Cellular mechanisms of lead neurotoxicity. Med Sci Monit. 2006;12:RA57–65.
  • Lidsky TI, Schneider JS. Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain. 2003;126:5–19.
  • Ding F, Dokholyan NV. Dynamical roles of metal ions and the disulfide bond in Cu, Zn superoxide dismutase folding and aggregation. Proc Natl Acad Sci USA. 2008;105:19696–701.
  • Vonk WI, Klomp LW. Role of transition metals in the pathogenesis of amyotrophic lateral sclerosis. Biochem Soc Trans. 2008;36:1322–8.
  • Fang F, Peters TL, Beard JD, Umbach DM, Keller J, Mariosa D, et al. Blood Lead, Bone Turnover, and Survival in Amyotrophic Lateral Sclerosis. Am J Epidemiol. 2017;186:1057–64.
  • Kamel F, Umbach DM, Stallone L, Richards M, Hu H, Sandler DP. Association of lead exposure with survival in amyotrophic lateral sclerosis. Environ Health Perspect. 2008;116:943–7.
  • Weisskopf MG, Webster TF. Trade-offs of personal vs. more proxy exposure measures in environmental epidemiology. Epidemiology 2017;28:635–43.
  • CReATe > Home. [Available from: https://www.rarediseasesnetwork.org/cms/create.
  • Cocco P, Dosemeci M, Heineman EF. Brain cancer and occupational exposure to lead. J Occup Environ Med. 1998;40:937–42.
  • Beard JD, Engel LS, Richardson DB, Gammon MD, Baird C, Umbach DM, et al. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis survival. PLoS One. 2017;12:e0185751.
  • Beard JD, Kamel F. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival. Epidemiol Rev. 2015;37:55–70.
  • Silbergeld EK, Sauk J, Somerman M, Todd A, McNeill F, Fowler B, et al. Lead in bone: storage site, exposure source, and target organ. Neurotoxicology 1993;14:225–36.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.